Fluvoxamine Open-Label Treatment of Adolescent Inpatients with Obsessive-Compulsive Disorder or Depression

ALAN APTER*, GIDI RATZONI, ROBERT A. KING, ABRAHAM WEIZMAN, IULIAN IANCU, MONICA BINDER, MARK A. RIDDLE

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

103 Scopus citations

Fingerprint

Dive into the research topics of 'Fluvoxamine Open-Label Treatment of Adolescent Inpatients with Obsessive-Compulsive Disorder or Depression'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences